The global market for tissue engineering and cell therapy — comprised solely of cells, tissues, extracellular matrices and directly related products — is growing at remarkable rates as a result of the positive benefit-to-cost ratio of these technologies. The demonstrable clinical benefits encompassing direct patient outcomes (at reduced healthcare expenditure) are driving expansion of these products to additional caseload at prices that favor continued development of technologies. Consequently, we anticipate that, at least through 2018 (and likely well beyond), growth in sales, by clinical application, of tissue engineering and cell therapy products will remain high.
Below are the market growth rates we predict for sales of tissue engineering and cell therapy products globally by area of clinical application.
Source: MedMarket Diligence, LLC; Report #S520, "Tissue Engineering, Cell Therapy and Transplantation: Products, Technologies & Market Opportunities, Worldwide, 2009-2018."